Zhejiang Ausun Pharmaceutical Co., Ltd.

Chine

 
Quantité totale PI 35
Rang # Quantité totale PI 40 447
Note d'activité PI 2,4/5.0    30
Rang # Activité PI 25 835
Symbole boursier 603229 (sse)
Capitalisation 13.254B  (CNY)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

19 0
0 0
16 0
0
 
Dernier brevet 2024 - Preparation method of lifitegras...
Premier brevet 2011 - Entecavir synthesis method and i...

Derniers inventions, produits et services

2024 Invention Intermediate compounds of pilocarpine and preparation method therefor. The present invention rela...
Invention Preparation method of pilocarpine and its intermediate compounds. The invention relates to a pro...
2023 Invention Preparation methods for pilocarpine and intermediate compound thereof. The present invention rela...
Invention Ruxolitinib crystal and pharmaceutical composition thereof. The invention relates to ruxolitinib...
Invention Ruxolitinib crystal and pharmaceutical composition thereof. A ruxolitinib crystal and a pharmaceu...
2022 Invention Method for preparation of asenapine. The present invention relates to a method for preparing Asen...
Invention Preparation method for miglitol. The present invention relates to a preparation method for miglit...
Invention Preparation method for intermediate compound acting as synthetic posaconazole, and intermediate c...
2021 Invention Preparation method of 5-bromo-2-chloro-benzoic acid as a synthetic raw material for hypoglycemic ...
Invention Method for preparing 5-bromo-2-chloro-benzoic acid as raw material in hypoglycemic drug synthesis...
Invention Preparation method of lifitegrast and intermediate compounds thereof. The invention relates to a...
Invention Method for preparing lifitegrast and intermediate compound of lifitegrast. A method for preparing...
Invention Synthesis and use of 1-benzyl-4-methyl-5-alkoxy-1,2,3,6-tetrahydropyridine derivative. The prese...
Invention Synthesis and use of 1-benzyl-4-methyl-5-alkoxy-1,2,3,6-tetrahydropyridine derivative. The presen...
Invention Application of bzp in treatment of ischemic cardiovascular and cerebral vascular diseases. The p...
Invention Application of bzp in treatment of ischemic cardiovascular and cerebral vascular diseases. The pr...
Invention Nebivolol synthesis method and intermediate compound thereof. The present invention relates to a...
2020 Invention Method of preparing asenapine. The present invention relates to a method for preparing asenapine....
2019 Invention Nebivolol synthesis method and intermediate compound thereof. The present invention relates to ne...
Invention 5-bromo-2-(alpha-hydroxypentyl)benzoic acid sodium salts in different crystal forms, and preparat...
2017 Invention Process for synthesis of eliglustat and intermediate compounds thereof. A method for synthesis of...
Invention Method for synthesis of eliglustat and intermediate compounds thereof. The present invention rela...
Invention Process for synthesis of eliglustat and intermediate compounds thereof. The present invention rel...
Invention 5-bromo-2-(α-hydroxypentyl)benzoic acid sodium salts in different crystal forms, and preparation ...
2016 Invention Posaconazole, composition, intermediate, preparation method and use thereof. 4 alkyl, substituted...
Invention Posaconazole, composition, intermediate, preparation method therefor, and uses thereof. The prese...
2015 Invention Nebivolol synthesis method and intermediate compound thereof. The present invention relates to a ...
2014 Invention 5-bromine-2-(α-hydroxypentyl)benzoic acid sodium salts in different crystal forms, and preparatio...
2013 Invention Synthetic intermediate of entecavir and method for preparing same. The present invention is relat...
2011 Invention Entecavir synthesis method and intermediate compound thereof. The present invention relates to a ...